Alnylam Pharmace. buy Citigroup Inc.
Start price
16.02.24
/
50%
€136.40
Target price
16.02.25
€210.72
Performance (%)
80.65%
End price
17.02.25
€246.40
Summary
This prediction ended on 17.02.25 with a price of €246.40. The BUY prediction by Citigroup_Inc_ for Alnylam Pharmace. saw massive gains of 80.65%. Citigroup_Inc_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Citigroup_Inc_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -2.939% | -2.939% | 13.932% |
| iShares Core DAX® | -1,50 % | 7,70 % | 5,24 % |
| iShares Nasdaq 100 | 1,38 % | 16,28 % | 36,09 % |
| iShares Nikkei 225® | -1,99 % | 13,11 % | 40,18 % |
| iShares S&P 500 | 0,35 % | 10,82 % | 26,47 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target lowered by analysts at Citigroup Inc. from $237.00 to $227.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€269.40
11.07.25
11.07.25
€346.03
11.07.26
11.07.26
-4.38%
29.04.26
29.04.26
Stopped prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€384.10
02.09.25
02.09.25
€498.17
02.09.26
02.09.26
-32.93%
29.04.26
29.04.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€261.50
21.03.25
21.03.25
€323.45
21.03.26
21.03.26
2.98%
22.03.26
22.03.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€247.40
02.08.24
02.08.24
€313.41
02.08.25
02.08.25
38.64%
03.08.25
03.08.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€225.00
25.06.24
25.06.24
€271.50
25.06.25
25.06.25
23.51%
26.06.25
26.06.25